Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: LNTH

Lantheus Holdings, Inc.

Healthcare | Drug Manufacturers - Specialty & Generic

No licensed closing price on file for LNTH. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$4.18

Lantheus Holdings, Inc. (NASDAQ: LNTH) is a specialty and generic drug manufacturer. Figures from SEC EDGAR; updated 2026-10-21 07:03 UTC.

What Lantheus Holdings, Inc. does

The company develops pharmaceutical products that depend on third-party service providers including contract research organizations and manufacturing partners, creating risks if these providers fail to perform or comply with requirements. Regulatory approval for new drugs is a lengthy, resource-intensive process requiring extensive clinical and preclinical data, and the FDA review can take many years with no guarantee of approval.

Summarized from Lantheus Holdings, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$4.18
Return on equity21.43%
Debt/equity0.43

Revenue, margins & earnings

FY2021: net loss $71M on revenue $425M$425MFY2021FY2022 Net income: $28MFY2022 Operating expenses: $546MFY2022 Cost of revenue: $353M$935MFY2022FY2023 Net income: $327MFY2023 Taxes & interest: $38MFY2023 Operating expenses: $345MFY2023 Cost of revenue: $587M$1.30BFY2023FY2024 Net income: $312MFY2024 Taxes & interest: $145MFY2024 Operating expenses: $531MFY2024 Cost of revenue: $546M$1.53BFY2024FY2025 Net income: $234MFY2025 Taxes & interest: $77MFY2025 Operating expenses: $631MFY2025 Cost of revenue: $600M$1.54BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-02
  • 2026-09-02CFO and TreasurerTax withholding-721$72.8K
  • 2026-08-19See RemarksTax withholding-2,536$255.9K
  • 2026-08-19Chief Accounting OfficerTax withholding-463$46.7K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Lantheus Holdings, Inc. do?

The company develops pharmaceutical products that depend on third-party service providers including contract research organizations and manufacturing partners, creating risks if these providers fail to perform or comply with requirements.

When did LNTH last file with the SEC?

Lantheus Holdings, Inc.'s most recent SEC filing on record is a 10-Q filed 2026-05-07. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-21 07:03 UTC. This page is also available as JSON at /api/data?ticker=LNTH and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for LNTH and 5,000+ tickers.

Create a free account — keep LNTH
For your agent
GET /api/data?ticker=LNTH

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt